Evaluating the real-world benefits and risks of anti-tumor necrosis factor therapies

J Rheumatol. 2013 Jan;40(1):4-6. doi: 10.3899/jrheum.121260.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Hospitalization / statistics & numerical data*
  • Humans
  • Male
  • Spondylitis, Ankylosing / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha